Molly Moloznik
Medical · Glendale, AZNPI 1164587226
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 422 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,281 and has fallen 50.7% since, to $1,124 in 2025. Among medical clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 422 payments — averaging $21.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$786
- LEO Pharma Inc.$735
- Sun Pharmaceutical Industries Inc.$652
- Sanofi$571
- Novartis$470
- plus $4K from 24 others
What the payments were for
- Food & beverage$8,77797%
- Education$2523%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 94 | $2,132 |
| Johnson & Johnson | 37 | $786 |
| LEO Pharma Inc. | 31 | $735 |
| Sun Pharmaceutical Industries Inc. | 26 | $652 |
| Sanofi | 26 | $571 |
| Novartis | 24 | $470 |
| Regeneron Healthcare Solutions, Inc. | 14 | $424 |
| UCB, Inc. | 19 | $394 |
| Lilly USA, LLC | 17 | $372 |
| Dermavant Sciences, Inc. | 29 | $322 |
| Incyte Corporation | 15 | $318 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 18 | $308 |
| Pfizer | 13 | $287 |
| E.r. Squibb & Sons, L.L.C. | 9 | $222 |
| Amgen | 9 | $182 |
| Galderma Laboratories, L.p. | 6 | $149 |
| Genentech USA, Inc. | 5 | $124 |
| Kyowa Kirin, Inc. | 4 | $96 |
| Almirall LLC | 4 | $85 |
| Journey Medical Corporation | 2 | $70 |
| Biofrontera Inc. | 3 | $69 |
| Organon | 5 | $46 |
| Botanix SB Inc | 2 | $43 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| Mayne Pharma Commercial LLC | 2 | $36 |
| Nabriva Therapeutics, PLC | 2 | $31 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Dermira, Inc. | 1 | $17 |
| EPI Health, LLC | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$114
How this compares
$9,029 in reported general payments places this provider in the 90th percentile of 748 medical providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 11 | $224,410 |
| Dupixent PenDupilumab | 15 | $54,448 |
| Tacrolimus | 15 | $2,939 |
| Clobetasol Propionate | 53 | $2,758 |
| Tretinoin | 22 | $1,775 |
| Fluorouracil | 24 | $1,665 |
| Ketoconazole | 78 | $1,663 |
| Betamethasone Dipropionate | 16 | $743 |
| Clindamycin Phosphate | 18 | $592 |
| Doxycycline Hyclate | 15 | $501 |
| ValacyclovirValacyclovir Hcl | 18 | $489 |
| Triamcinolone Acetonide | 35 | $292 |
| Ciclopirox | 11 | $215 |
Paid to pharmacies, not to this prescriber.
Other medical in Glendale
- Kaitlyn HasanGlendale$16K
- David BeckGlendale$8K
- Robert CasquejoScottsdale$474K
- Andrew HicksPeoria$460K
- Darren WestScottsdale$206K
- Linda MoorsTucson$122K
- Jamie WystrachScottsdale$79K
- Scott YoungPhoenix$69K
- Scott LightfootPhoenix$61K
- Jennifer KiserPhoenix$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.